Clinical and Methodologic Considerations With Regard to a Trial of Nintedanib in Patients With Systemic Sclerosis‐Associated Interstitial Lung Disease: Comment on the Reanalysis by Maher et al. Issue 12 (20th October 2021)

Record Type:: Journal Article
Title:: Clinical and Methodologic Considerations With Regard to a Trial of Nintedanib in Patients With Systemic Sclerosis‐Associated Interstitial Lung Disease: Comment on the Reanalysis by Maher et al. Issue 12 (20th October 2021)
Main Title:: Clinical and Methodologic Considerations With Regard to a Trial of Nintedanib in Patients With Systemic Sclerosis‐Associated Interstitial Lung Disease: Comment on the Reanalysis by Maher et al
Authors:: Bredemeier, Markus
Abstract:
Is Part Of:: Arthritis & rheumatology. Volume 73:Issue 12(2021)
Journal:: Arthritis & rheumatology
Issue:: Volume 73:Issue 12(2021)
Issue Display:: Volume 73, Issue 12 (2021)
Year:: 2021
Volume:: 73
Issue:: 12
Issue Sort Value:: 2021-0073-0012-0000
Page Start:: 2353
Page End:: 2354
Publication Date:: 2021-10-20
Subjects:: Arthritis -- Periodicals
Rheumatism -- Periodicals
616.72
Journal URLs:: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2326-5205 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1002/art.41893 ↗
Languages:: English
ISSNs:: 2326-5191
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1733.820000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 20215.xml